Search results
Siliq and cost: Reducing long-term drug costs and more
Medical News Today· 4 days agoSiliq (brodalumab) is a brand-name subcutaneous injection prescribed for plaque psoriasis in adults...
Amjevita and dosage: Strengths, forms, how to inject, and more
Medical News Today· 4 days agoAmjevita comes as a solution subcutaneous injection. Your doctor will determine the best dosage to...
What Is Psoriatic Arthritis? 3 MDs Weigh In
PopSugar· 6 days agoPsoriasis affects about three percent of American adults, but the disorder can raise the risk of having more than skin scales and plaques. About 30 percent ...
Tapinarof Cream for Adult, Pediatric Eczema Under FDA Review
Medscape· 7 days agoA decision on approval is expected in the fourth quarter of 2024.
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 5 days agoGuselkumab has been approved in the EU to treat moderate to severe plaque psoriasis in adults who...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 4 days agoTremfya is presently approved to treat certain patients with plaque psoriasis and active psoriatic...
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Medscape· 5 days agoUnlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.
PhRMA to Revive Medicare Drug Price Lawsuit Before Fifth Circuit
Bloomberg Law· 7 days agoA health provider trade association, a patient advocacy group, and a top drug lobby will attempt to restore their case against a government drug price-setting ...
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First...
Morningstar· 7 days agoU.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab) Alvotech will manufacture ...
